At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the success of a pharmaceutical tablet relies not only on its active ingredients but also on the manufacturing process and the excipients employed. Croscarmellose Sodium (CCS) is a highly versatile superdisintegrant that performs exceptionally well in both direct compression and wet granulation processes, offering formulators significant flexibility. This article examines its role in each method and provides insights for choosing the optimal approach.
Direct compression is a manufacturing technique that streamlines tablet production by directly compressing the blend of API and excipients into tablets without prior granulation. For this process to be successful, the formulation must possess excellent flowability and compressibility. Croscarmellose Sodium is an ideal disintegrant for direct compression because it has good flow properties and its disintegrating action is not significantly compromised by the compression forces, unlike some other disintegrants.
In contrast, wet granulation involves mixing powders with a binder solution to form granules, which are then dried and compressed. This process is often used to improve flowability and compressibility of formulations that are not suitable for direct compression. Croscarmellose Sodium, when incorporated into formulations for wet granulation, also demonstrates excellent performance. It can be added either intragranularly or extragranularly, or both, to ensure effective disintegration. Its ability to swell and wick water remains robust even after the granulation and drying steps.
The choice between direct compression and wet granulation often depends on the specific API, other excipients, and the desired tablet characteristics. However, the consistent performance of Croscarmellose Sodium in both methods simplifies this decision-making process for pharmaceutical manufacturers. Its ability to provide rapid disintegration and enhance drug release makes it a preferred choice, regardless of the chosen manufacturing route. Manufacturers often investigate croscarmellose sodium in direct compression and its efficacy in wet granulation to optimize their production lines.
NINGBO INNO PHARMCHEM CO.,LTD. supplies high-quality Croscarmellose Sodium that guarantees optimal performance in your chosen tablet manufacturing process. By understanding the nuances of croscarmellose sodium wet granulation and direct compression, pharmaceutical companies can achieve efficient production and superior final products.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.